One size does not fit all: Perioperative management of patients with heart failure with preserved ejection fraction

被引:0
作者
Gao, Wei Dong [1 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD 21218 USA
关键词
PULMONARY ARTERIAL CAPACITANCE; OBSTRUCTIVE SLEEP-APNEA; DISEASE; HYPERTENSION; MECHANISMS; GUIDELINES; PHENOTYPE; PRESSURE; OUTCOMES;
D O I
10.1016/j.jclinane.2024.111409
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Heart failure with preserved ejection fraction (HFpEF) is recognized as an important risk factor for perioperative complications. However, anesthesia management of HFpEF patients remains a considerable challenge without clear guidance. HFpEF is heterogeneous in its pathophysiological processes, diverse clinical presentations, adverse remodeling of cardiovascular and other organs, and clinical outcomes. It is difficult to manage the disease with one fixed approach because of this. This review phenotypes HFpEF patients by combining their clinical features and anesthesia care issues. Five phenotypes of HFpEF patients are identified: A, O, P, C, and Y. The clinical features, anesthesia implications, and anesthesia management for each phenotype are highlighted and discussed. Such an approach to HFpEF patients in the operating room could deliver safe, high-quality perioperative care.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] The Role of Mineralocorticoid Receptor Antagonists in the Management of Heart Failure with Preserved Ejection Fraction
    Papagiannis, Achilleas
    Alkagiet, Stelina
    Tziomalos, Konstantinos
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (46) : 5525 - 5527
  • [32] Acute Decompensated Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction
    Sugimoto, Tadafumi
    HEART FAILURE CLINICS, 2020, 16 (02) : 201 - +
  • [33] Phenotypic Persistence in Heart Failure With Preserved Ejection Fraction
    Paulus, Walter J.
    CIRCULATION-HEART FAILURE, 2019, 12 (03)
  • [34] Ivabradine for Treatment of Heart Failure With Preserved Ejection Fraction
    Babushkina, G. V.
    Shaykhlislamova, G. I.
    KARDIOLOGIYA, 2020, 60 (10) : 33 - 37
  • [35] Heart Failure with Preserved Ejection Fraction: An Ongoing Enigma
    Rose-Jones, Lisa J.
    Rommel, John J.
    Chang, Patricia P.
    CARDIOLOGY CLINICS, 2014, 32 (01) : 151 - +
  • [36] Is Heart Failure with Preserved Ejection Fraction a Kidney Disorder?
    Shah, Kevin S.
    Fang, James C.
    CURRENT HYPERTENSION REPORTS, 2019, 21 (11)
  • [37] Management of hypertension in heart failure with preserved ejection fraction: is there a blood pressure goal?
    Myhre, Peder L.
    Selvaraj, Senthil
    Solomon, Scott D.
    CURRENT OPINION IN CARDIOLOGY, 2021, 36 (04) : 413 - 419
  • [38] Heart failure with preserved ejection fraction: A clinical crisis
    Banerjee, Prithwish
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 204 : 198 - 199
  • [39] Reshaping Treatment of Heart Failure with Preserved Ejection Fraction
    Karamichalakis, Nikolaos
    Xanthopoulos, Andrew
    Triposkiadis, Filippos
    Paraskevaidis, Ioannis
    Tsougos, Elias
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [40] Homocysteine Levels in Patients with Heart Failure with Preserved Ejection Fraction
    Okuyan, Ertugrul
    Uslu, Ahmet
    Cakar, Mehmet Akif
    Sahin, Irfan
    Onur, Imran
    Enhos, Asim
    Biter, Halil Ibrahim
    Cetin, Sukru
    Dinckal, Mustafa Hakan
    CARDIOLOGY, 2010, 117 (01) : 21 - 27